Invention Grant
- Patent Title: Immunogenic composition for MERS coronavirus infection
-
Application No.: US14375083Application Date: 2014-02-28
-
Publication No.: US09889194B2Publication Date: 2018-02-13
- Inventor: Shibo Jiang , Lanying Du , Yusen Zhou , Guangyu Zhao
- Applicant: New York Blood Center, Inc. , Yusen Zhou , Guangyu Zhao
- Applicant Address: US NY New York
- Assignee: New York Blood Center, Inc.
- Current Assignee: New York Blood Center, Inc.
- Current Assignee Address: US NY New York
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Michelle Glasky Bergman
- International Application: PCT/US2014/019402 WO 20140228
- International Announcement: WO2014/134439 WO 20140904
- Main IPC: A61K39/215
- IPC: A61K39/215 ; C07K16/10 ; C12N7/00 ; A61K39/12 ; C07K14/005 ; A61K39/385 ; A61K39/00
Abstract:
Described herein are immunogenic compositions for preventing infection with Middle East respiratory syndrome coronavirus (MERS-CoV) wherein the immunogenic compositions comprise at least a portion of the MERS-CoV S protein and an immunopotentiator.
Public/Granted literature
- US20160296617A1 Immunogenic Composition for MERS Coronavirus Infection Public/Granted day:2016-10-13
Information query
